Suppr超能文献

含溴半胱氨酸S-共轭物及相关化合物的结构-诱变性和结构-细胞毒性研究

Structure-mutagenicity and structure-cytotoxicity studies on bromine-containing cysteine S-conjugates and related compounds.

作者信息

Finkelstein M B, Vamvakas S, Bittner D, Anders M W

机构信息

Department of Pharmacology, University of Rochester, New York 14642.

出版信息

Chem Res Toxicol. 1994 Mar-Apr;7(2):157-63. doi: 10.1021/tx00038a007.

Abstract

Glutathione and cysteine S-conjugates of several haloalkenes are nephrotoxic and cytotoxic. Chloroalkene-derived S-(1-chloroalkenyl)-L-cysteine conjugates, but not fluoroalkene-derived S-(2,2-dihalo-1,1-difluorethyl)-L-cysteine conjugates, are mutagenic in the Ames test, although both types of S-conjugates are cytotoxic and nephrotoxic. Recent studies showed that bromine-containing S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteine conjugates are mutagenic in the Ames test, thus challenging the generalization that S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteine conjugates are not mutagenic. Hence a series of bromine-containing and bromine-lacking S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteine conjugates was prepared, and their mutagenicity was assessed in the Ames test with Salmonella typhimurium TA2638 as the test strain. In addition, several indices of cytotoxicity, including cytotoxicity in LLC-PK1 cells, induction of Ca2+ release from pig kidney mitochondria, and DNA double-strand breaks in LLC-PK1 cells, were measured. The bromine-containing S-conjugates S-(2-bromo-2-chloro-1,1-difluoroethyl)-L- cysteine (BCD-FC), S-(2-bromo-1,1,2-trifluoroethyl)-L-cysteine (BTFC), and S-(2,2-dibromo-1,1-difluoroethyl)-L-cysteine (DBDFC) were mutagenic in the Ames test, whereas S-(2-chloro-1,1,2-trifluorethyl)-L-cysteine (CTFC), S-(2,2-dichloro-1,1-difluoroethyl)-L-cysteine (DCDFC), and S-(1,1,2,2-tetrafluoroethyl)-L-cysteine (TFC), which lack bromine, were not. BCDFC, BTFC, CTFC, DBDFC, and TFC were cytotoxic in LLC-PK1 cells, and their cytotoxicity was blocked by the cysteine conjugate beta-lyase inhibitor (aminooxy)acetic acid.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

几种卤代烯烃的谷胱甘肽和半胱氨酸S-共轭物具有肾毒性和细胞毒性。氯代烯烃衍生的S-(1-氯代烯基)-L-半胱氨酸共轭物在艾姆斯试验中具有致突变性,而氟代烯烃衍生的S-(2,2-二卤-1,1-二氟乙基)-L-半胱氨酸共轭物则不具有致突变性,尽管这两种类型的S-共轭物都具有细胞毒性和肾毒性。最近的研究表明,含溴的S-(2,2-二卤-1,1-二氟乙基)-L-半胱氨酸共轭物在艾姆斯试验中具有致突变性,这对S-(2,2-二卤-1,1-二氟乙基)-L-半胱氨酸共轭物不具有致突变性这一普遍观点提出了挑战。因此,制备了一系列含溴和不含溴的S-(2,2-二卤-1,1-二氟乙基)-L-半胱氨酸共轭物,并以鼠伤寒沙门氏菌TA2638作为测试菌株,在艾姆斯试验中评估它们的致突变性。此外,还测量了几种细胞毒性指标,包括LLC-PK1细胞中的细胞毒性、猪肾线粒体中Ca2+释放的诱导以及LLC-PK1细胞中的DNA双链断裂。含溴的S-共轭物S-(2-溴-2-氯-1,1-二氟乙基)-L-半胱氨酸(BCD-FC)、S-(2-溴-1,1,2-三氟乙基)-L-半胱氨酸(BTFC)和S-(2,2-二溴-1,1-二氟乙基)-L-半胱氨酸(DBDFC)在艾姆斯试验中具有致突变性,而不含溴的S-(2-氯-1,1,2-三氟乙基)-L-半胱氨酸(CTFC)、S-(2,2-二氯-1,1-二氟乙基)-L-半胱氨酸(DCDFC)和S-(1,1,2,2-四氟乙基)-L-半胱氨酸(TFC)则不具有致突变性。BCD-FC、BTFC、CTFC、DBDFC和TFC在LLC-PK1细胞中具有细胞毒性,并且它们的细胞毒性被半胱氨酸共轭β-裂解酶抑制剂(氨氧基)乙酸所阻断。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验